This may be surprising as the frequency of CD20+ T cells in blood is higher in patients with RRMS (21) and since these patients concomitantly have an increased CSF level of CXCL10 (31, 32), which has the potential to attract CXCR3-expressing cells. Here, CXCR3 is linked to relapsing-remitting multiple sclerosis.